Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,029 across all filing types
Latest filing 2025-05-12 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It details the number of shares purchased, the price paid, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It provides specific details such as the date of purchase, the number of shares, the price paid, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-09 English
Autolus reports Q1 2025 Financial Results
Earnings Release Classification · 1% confidence The document is an announcement from Syncona Limited regarding the financial results of its portfolio company, Autolus Therapeutics plc, for the first quarter ended March 31, 2025. It contains key financial highlights, operational updates, and consolidated financial data tables. While it is distributed via an RNS (Regulatory News Service) header, the content itself is a comprehensive summary of quarterly financial performance and business updates, which fits the definition of an Earnings Release (ER). Q1 2025
2025-05-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from Syncona Limited regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It provides specific details on the number of shares purchased, the price paid, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Syncona Limited detailing the purchase of its own shares (share buyback) on the London Stock Exchange. It provides specific transaction details such as the number of shares purchased, the price paid, and the impact on total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-05-07 English
Beacon presents positive data
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement (RNS) issued by Syncona Limited regarding positive clinical trial data from its portfolio company, Beacon Therapeutics. It follows the standard format of a London Stock Exchange RNS, providing a summary of the trial results and including the full text of the portfolio company's announcement. Since it is a general regulatory announcement regarding company news and portfolio updates, it falls under the RNS category.
2025-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.